Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/57746
Full metadata record
DC FieldValueLanguage
dc.contributor.authorApichat Tantraworasinen_US
dc.contributor.authorSomcharoen Saetengen_US
dc.contributor.authorSophon Siwachaten_US
dc.contributor.authorTawatchai Jiarawasupornchaien_US
dc.contributor.authorNirush Lertprasertsukeen_US
dc.contributor.authorSarawut Kongkarnkaen_US
dc.contributor.authorChidchanok Ruengornen_US
dc.contributor.authorJayanton Patumanonden_US
dc.contributor.authorEmanuela Taiolien_US
dc.contributor.authorRaja M. Floresen_US
dc.date.accessioned2018-09-05T03:49:06Z-
dc.date.available2018-09-05T03:49:06Z-
dc.date.issued2017-03-01en_US
dc.identifier.issn20776624en_US
dc.identifier.issn20721439en_US
dc.identifier.other2-s2.0-85016503744en_US
dc.identifier.other10.21037/jtd.2017.02.90en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85016503744&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/57746-
dc.description.abstractBackground: A surgical lung resection with systematic mediastinal lymph node (LN) dissection is recommended by the National Comprehensive Cancer Network guideline. However, the effective number of dissected LNs, stations and positivity is still controversial. The aim of this study is to identify the impact of total numbers, LN stations and positivity of dissected LNs on tumor recurrence and overall death in resectable non-small cell lung cancer (NSCLC). Methods: This prognostic study used a retrospective data collection design. Adult patients with clinical resectable NSCLC who underwent pulmonary resection and mediastinal lymphadenectomy at Chiang Mai University between June 2000 and June 2012 were enrolled in this study. A multilevel mixed-effects parametric survival model was used to identify the effect of numbers, LN stations and positivity of dissected LNs to tumor recurrence and mortality. Results: The average number of dissected LNs was 22.7±12.8. Tumor recurrence was found in 51.3% and overall mortality was 43.3%. The number of dissected LNs was a prognostic factor for tumor recurrence [HR 0.98, 95% confidence interval (CI): 0.96-0.99]. There was a significant difference at the cut-pointed value of 11 dissected LNs for tumor recurrence (HR 2.22, 95% CI: 1.26-3.92). Dissection less than 11 nodes and less than 5 stations indicated a poor prognostic factor for tumor recurrence: for 3-4 stations (HR 3.01, 95% CI: 1.22-7.42) and for 1-2 stations (HR 1.96, 95% CI: 1.04-3.72). The positivity of dissected LNs was also a prognostic factor for tumor recurrence and overall mortality (HR 1.01, 95% CI: 1.01-1.02 and HR 1.01, 95% CI: 1.01-1.03, respectively). Conclusions: Eleven or more LN dissection with at least 5 stations influenced recurrent-free survival. Systematic LN dissection (SLND) should be performed not only to identify the positivity of dissected LNs but also to determine an accurate tumor nodal stage. A larger cohort should be further conducted to support these findings.en_US
dc.subjectMedicineen_US
dc.titleImpact of lymph node management on resectable non-small cell lung cancer patientsen_US
dc.typeJournalen_US
article.title.sourcetitleJournal of Thoracic Diseaseen_US
article.volume9en_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsThammasat Universityen_US
article.stream.affiliationsSinai Health Systemen_US
article.stream.affiliationsIcahn School of Medicine at Mount Sinaien_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.